Header Logo

Kimberly Lenz

Concepts (83)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medicaid
10
2019
362
0.670
 Why?
Analgesics, Opioid
4
2019
531
0.560
 Why?
Pain
3
2019
407
0.550
 Why?
Medication Therapy Management
3
2018
21
0.370
 Why?
Antiviral Agents
3
2018
329
0.320
 Why?
Practice Patterns, Physicians'
5
2019
708
0.300
 Why?
Hepatitis C
2
2016
152
0.220
 Why?
United States
10
2019
7923
0.160
 Why?
Drug Utilization Review
2
2017
52
0.160
 Why?
Chloride Channel Agonists
1
2019
3
0.160
 Why?
Drug and Narcotic Control
2
2017
28
0.160
 Why?
Aminophenols
1
2019
4
0.160
 Why?
Benzodioxoles
1
2019
14
0.160
 Why?
Aminopyridines
1
2019
36
0.150
 Why?
Quinolones
1
2019
30
0.150
 Why?
Uridine Monophosphate
1
2018
9
0.140
 Why?
Fluorenes
1
2018
15
0.140
 Why?
Cystic Fibrosis
1
2019
124
0.140
 Why?
Benzimidazoles
1
2018
56
0.140
 Why?
Psychotropic Drugs
1
2018
82
0.140
 Why?
Insurance, Pharmaceutical Services
2
2014
19
0.130
 Why?
Hydrocodone
1
2017
7
0.130
 Why?
Hepatitis C, Chronic
1
2018
89
0.130
 Why?
Drug Prescriptions
1
2018
170
0.130
 Why?
Hepacivirus
1
2018
140
0.130
 Why?
Opioid-Related Disorders
2
2014
513
0.130
 Why?
Progesterone
1
2017
163
0.130
 Why?
Premature Birth
1
2017
115
0.120
 Why?
Medication Adherence
1
2017
205
0.120
 Why?
Prescription Drug Diversion
1
2014
7
0.110
 Why?
Lung
1
2019
964
0.110
 Why?
Prescription Drug Misuse
1
2014
21
0.110
 Why?
State Government
1
2014
32
0.110
 Why?
Drug Combinations
3
2019
168
0.100
 Why?
Drug Interactions
1
2014
126
0.100
 Why?
Managed Care Programs
1
2014
89
0.100
 Why?
Retrospective Studies
7
2018
6740
0.100
 Why?
Health Services Accessibility
1
2016
575
0.080
 Why?
Mental Disorders
1
2018
794
0.080
 Why?
Treatment Outcome
3
2016
5696
0.080
 Why?
Young Adult
4
2019
4781
0.070
 Why?
Adolescent
4
2019
6305
0.070
 Why?
Adult
6
2019
17134
0.060
 Why?
Humans
10
2019
64283
0.060
 Why?
Drug Costs
2
2016
57
0.060
 Why?
Cost Savings
2
2016
55
0.060
 Why?
Cost-Benefit Analysis
2
2017
318
0.050
 Why?
Female
7
2019
33382
0.050
 Why?
Program Evaluation
2
2018
490
0.050
 Why?
Middle Aged
5
2019
17921
0.050
 Why?
Pharmacists
2
2016
129
0.050
 Why?
Male
6
2019
30322
0.050
 Why?
Massachusetts
2
2018
2096
0.050
 Why?
Cohort Studies
2
2017
2605
0.040
 Why?
Child
2
2019
4583
0.040
 Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2019
79
0.040
 Why?
Sustained Virologic Response
1
2018
10
0.040
 Why?
Ribavirin
1
2018
23
0.040
 Why?
Sofosbuvir
1
2018
19
0.040
 Why?
Polypharmacy
1
2018
61
0.030
 Why?
Treatment Failure
1
2018
201
0.030
 Why?
Hydroxyprogesterones
1
2017
6
0.030
 Why?
Controlled Substances
1
2017
5
0.030
 Why?
Viral Load
1
2018
233
0.030
 Why?
Drug Therapy, Combination
1
2018
467
0.030
 Why?
Dose-Response Relationship, Drug
1
2019
869
0.030
 Why?
RNA, Viral
1
2018
276
0.030
 Why?
Gestational Age
1
2017
191
0.030
 Why?
Psychiatry
1
2018
127
0.030
 Why?
Genotype
1
2018
668
0.030
 Why?
Insurance Claim Review
1
2016
76
0.030
 Why?
Evidence-Based Medicine
1
2018
462
0.030
 Why?
Pregnancy Outcome
1
2017
195
0.030
 Why?
Drug Monitoring
1
2016
206
0.030
 Why?
Government Regulation
1
2014
41
0.030
 Why?
Interdisciplinary Communication
1
2014
107
0.030
 Why?
Physician's Role
1
2014
124
0.020
 Why?
Cooperative Behavior
1
2014
226
0.020
 Why?
Health Policy
1
2014
195
0.020
 Why?
Mutation
1
2019
2633
0.020
 Why?
Pregnancy
1
2017
2370
0.020
 Why?
Time Factors
1
2014
3725
0.020
 Why?
Aged
1
2018
14662
0.010
 Why?
Lenz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (83)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_